Neuland Laboratories Limited (NEULANDLAB.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 154.31B |
| Enterprise Value | 156.55B |
| P/E Ratio | 60.66 |
| PEG Ratio | 0.33 |
| Price/Sales Ratio | 12.73 |
| Price/Book Ratio | 16.11 |
| Enterprise/Revenue | 12.73 |
| Enterprise/EBITDA | 38.04 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.21 |
| Operating Margin | 0.28 |
AD
Management Effectiveness
| Return On Assets | 0 |
| Return On Equity | 0.28 |
Income Statement
| Revenue | 20.23B |
| Revenue/Share | 1,848.65 |
| Gross Profit | 6.43B |
| EBITDA | 6.05B |
| Net Income | 3.64B |
| Diluted EPS | 283.71 |
Balance Sheet
| Total Cash | 766.7M |
| Total Cash/Share | 0 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0 |
| Book Value Per Share | 1,461.01 |
Price History
| 52-Week Change | 51.31 |
| 52-Week High | 24,225 |
| 52-Week Low | 11,500 |
| Moving Average 50 Days | 21,147.04 |
| Moving Average 200 Days | 16,457.37 |
Statistics
| Average Volume | 64,999 |
| Shares Outstanding | 12.83M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 34 |
| Trailing Annual Dividend Yield | 0.14 |
| Payout Ratio | 0.03 |
| Last Split Factor | 523:500 |
| Last Split Date | August 13, 2014 |
AD
